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Table 1 (Abstr. M60). Mean RT values per 100,000 cells per day of viral 
accumulation
 Day Control Pol High Pol Low Pur High Pur Low
2 3.2E6 
± 0.5E6
3.8E6 
± 0.4E6
4.9E6 
± 0.9E6
13.6E6 
± 0.4E6
13.4E6 
± 4.9E6
4 12.7E6 
± 2.7E6
13.7E6 
± 1.5E6
15.2E6 
± 1.3E6
720.6E6 
± 341.6E6
59.1E6 
± 21.8E6
7 8.6E6 
± 1.7E6
13.8E6 
± 2.5E6
17.4E6 
± 3.3E6
527.1E6 
± 210.1E6
21.6E6 
± 5.9E6
9 27.9E6 
± 1.8E6
27.7E6 
± 1.5E6
28.4E6 
± 6.5E6
529.4E6 
± 104.4E6
27.4E6 
± 1.5E6
13 9.7E6 
± 0.8E6
12.0E6 
± 3.1E6
9.9E6 
± 0.9E6
215.0E6 
± 13.5E6
6.5E6 
± 0.8E6
17 5.2E6 
± 1.0E6
7.0E6 
± 1.7E6
6.4E6 
± 0.8E6
198.6E6 
± 11.7E6
4.2E6 
± 0.3E6
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Autoaggregation in bacteria is the phenomenon of aggregation between 
cells of the same strain, whereas coaggregation is due to aggregation 
occurring among different species. Aggregation ability of prebiotic 
bacteria is related to adhesion ability, which is a prerequisite for the 
colonization and protection of the gastrointestinal tract in all animal 
species; however, coaggregation ability of prebiotic bacteria offers a 
possibility of close interaction with pathogenic bacteria. Coaggregation 
ability of cell wall components of Saccharomyces cerevisiae is known, 
because of their mannan content, but literature offers little information 
on this topic. The aim of this experiment was to assess the ability of 
coaggregation of 2 preparations of S. cerevisiae cell walls to 3 pathogenic 
bacteria (Staphylococcus aureus hemolytic enterotoxin A, Salmonella 
enteritidis and Escherichia coli serotype O157:H/7). Cell wall prepa-
rations consisted on either the distillery cream (DT), a byproduct of 
sugar cane, or a hydrolyzate (HT) obtained by enzymatic methods. 
Pathogens were grown in nutritive broth medium for 18 h at 37°C. 
After that, cultures were diluted (1:1) with DT and HT, and absorbance 
(560λ) was measured at 0 and 5 h. Both DT and HT showed the ability 
of coaggregate to the 3 pathogenic strains, and no bacterial strain × cell 
wall preparation interaction (P = 0.379) was detected. Coaggregation 
was higher (P < 0.001; SEM = 0.36) with HT (mean values of 85.3, 
78.6 and 77.8% for S. aureus, S. enteritidis, and E. coli, respectively) 
compared with DT (mean values of 16.5, 5.8 and 6.0% for S. aureus, S. 
enteritidis, and E. coli, respectively). If confirmed with other pathogen 
species, these results support further research on the use of the HT from 
S. cerevisiae as a possible prebiotic additive for animal feed.
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The aims of this study were to investigate (1) the efficacy of chitosan 
in 2 forms, the monomer N-acetyl glucosamine (NAG) and a chloride 
salt of chitosan (MIX) in culture systems HCT-8 and Caco-2 cell lines 
in vitro for Cryptosporidium parvum compared with a positive control, 
paromomycin (PARO) a classical drug used in veterinary medicine; 
(2) the action of a chitosan-yeast-bacteria based product on neonatal 
diarrhea and mortality in goat kids. Cryptosporidiosis is considered 
as an economically important disease with clinical signs and death in 
young ruminants. The usual clinical symptom is acute diarrhea affecting 
animals from 1 to 3 weeks old. As no drugs are fully effective in the 
treatment of cryptosporidiosis in man and animals, the research for new 
therapeutic agents is crucial. Chitosan is a sugar that is obtained from 
the hard outer skeleton of shellfish, including crab and shrimp and it 
is used in medicine. It has been found to be active against a variety of 
diseases including antimicrobial and anti-tumoral effects. Immunofluo-
rescence technique was used for the identification and enumeration of 
the parasites. The results showed a significant reduction of viability of 
Cryptosporidium oocysts (>95%) after pre-incubation of 24h at 37°C 
with PARO (P < 0.001), MIX and NAG (P < 0.001). Additionally, 
PARO, MIX and NAG inhibited significantly the development of C. 
parvum in HCT-8 and Caco-2 cell lines (P < 0.005). These effects were 
dose-dependent. Synergistic effects were obtained when NAG treatment 
was associated with Paromomycin. The efficacy of MIX in combination 
with yeast and bacteria (Optisaf FIRST, Phileo, France) was evaluated 
experimentally in goat neonates inoculated with C. parvum oocystes 
(106 oocytes/mL) per oral route. Preliminary results showed a signifi-
cant reduction in oocyst shedding and diarrhea score in goat kids and 
mortality was significantly reduced (36%) in treated animals (P < 0.05) 
compared with the control group (90%). In conclusion, these findings 
provide evidence of in vitro inhibitory activities of chitosan against C. 
parvum and its combination with yeast-based products revealed promis-
ing in lessening the incidence of neonatal diarrhea in young ruminants.
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